InvestorsHub Logo
Followers 800
Posts 50882
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Friday, 11/19/2021 10:35:27 AM

Friday, November 19, 2021 10:35:27 AM

Post# of 89
Bluejay Diagnostics, Inc. is an in-vitro diagnostic company. The Company is engaged in the developing and marketing minimally invasive point of care (POC) diagnostics tests and devices that provide patients and providers with access to healthcare. The Company offers diagnostic testing in infectious, inflammatory and metabolic diseases by using its Symphony platform. It focuses on offering solution to the infectious disease, inflammation, and oncology markets. The Company’s ALLEREYE diagnostic test (ALLEREYE) is a POC device that offers healthcare providers a solution for diagnosis of allergic conjunctivitis. The Company's product candidate includes Symphony IL-6 Sepis triage, Symphony IL-6 LDT market, Symphony IL-6 SEPSIS, Symphony hsTNT/I and NT-proBNP. It is utilizing the platform for detection of sepsis, cancer and other diseases. It is also developing biomarkers for detection of other diseases, such as cardiac ischemia and congestive heart failure.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BJDX News